Assessing bronchodilator reversibility: agreed standards are urgently needed

Editorial

Christine Jenkins et al. Med J Aust. 2004.

. 2004 Jun 21;180(12):605-6.

doi: 10.5694/j.1326-5377.2004.tb06119.x.

No abstract available

Comment on

Bronchodilator reversibility testing: laboratory practices in Australia and New Zealand.
Borg BM, Reid DW, Walters EH, Johns DP. Borg BM, et al. Med J Aust. 2004 Jun 21;180(12):610-3. doi: 10.5694/j.1326-5377.2004.tb06121.x. Med J Aust. 2004. PMID: 15200356

Bronchodilator reversibility testing: laboratory practices in Australia and New Zealand.
Borg BM, Reid DW, Walters EH, Johns DP. Borg BM, et al. Med J Aust. 2004 Jun 21;180(12):610-3. doi: 10.5694/j.1326-5377.2004.tb06121.x. Med J Aust. 2004. PMID: 15200356
Substantial variation exists in spirometry interpretation practices for airflow obstruction in accredited lung function laboratories across Australia and New Zealand.
Holt NR, Thompson BR, Miller B, Borg BM. Holt NR, et al. Intern Med J. 2019 Jan;49(1):41-47. doi: 10.1111/imj.14047. Intern Med J. 2019. PMID: 30043534
Sharpening the clinical diagnostic borders of chronic obstructive pulmonary disease.
Jenkins C. Jenkins C. Intern Med J. 2003 Dec;33(12):551-3. doi: 10.1111/j.1445-5994.2003.00498.x. Intern Med J. 2003. PMID: 14656225 No abstract available.
Diagnosis and treatment of patients with chronic obstructive pulmonary disease in the primary care setting: focus on the role of spirometry and bronchodilator reversibility.
Stoloff SW. Stoloff SW. J Fam Pract. 2011 Apr;60(4 Suppl Diagnosis):S9-16. J Fam Pract. 2011. PMID: 21472146 Review. No abstract available.
[COPD and Asthma: same same but different].
Rothe T. Rothe T. Praxis (Bern 1994). 2012 Feb 15;101(4):233-7. doi: 10.1024/1661-8157/a000835. Praxis (Bern 1994). 2012. PMID: 22337513 Review. German.